Natesto

Quick links to important sections

Natesto

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Natesto

Property Description
Active ingredient Testosterone
Form Intranasal gel (metered-dose pump)
Pharmacological class Androgen (Anabolic Androgenic Steroid)
Common use Testosterone Replacement Therapy (TRT)
Origin Synthetic

Natesto is a brand-name prescription medicine used for Testosterone Replacement Therapy (TRT) in adult males who have a documented deficiency or absence of endogenous testosterone production. The medicine is formally classified as an androgen and belongs to the class of Anabolic Androgenic Steroids. This pharmaceutical entity's core function is to address medical conditions linked to insufficient androgen levels by providing external hormonal supplementation.


Composition and Unique Intranasal Gel Form

The active ingredient in this medication is testosterone, which is produced synthetically to be chemically identical to the hormone naturally found in the body. The unique dosage form is an intranasal gel dispensed via a specialized metered-dose pump, which is a primary differentiating factor from traditional testosterone gels applied to the skin (transdermal). This single-active ingredient product is an aqueous gel base designed for application to the nasal mucosa. Pharmacological studies have supported the efficacy of intranasal administration as a reliable delivery method for testosterone.

General Purpose and Mechanism of Action

The overarching physiological action of Natesto is hormone replacement, intended to establish and maintain testosterone levels within the normal, healthy range typically found in adult males. The intranasal gel facilitates this by allowing the rapid systemic absorption of the testosterone through the nasal lining. By providing the essential hormone, the general purpose is to mitigate the systemic effects that arise when a male has low androgen levels.

What side effects are possible with Natesto?

Official Regulatory Safety Profile

The safety profile for this medicine, classified as an androgen, is officially documented by regulatory agencies and includes adverse reactions specific to the intranasal delivery route, alongside systemic risks common to all testosterone replacement therapies. The regulatory label classifies adverse reactions based on their frequency in clinical trials, with certain effects noted as common (occurring in ge 2% of patients).

Commonly Documented Adverse Reactions (ge 2% incidence)

Adverse reactions most frequently reported are often related to the site of administration, categorized under Respiratory, Thoracic and Mediastinal Disorders. These include nasal discomfort, epistaxis (nosebleed), nasal irritation, and rhinorrhea (runny nose). Systemic common effects documented include headache, fatigue, and increases in Prostate-Specific Antigen (PSA) levels.

Serious Adverse Reactions and Class Warnings

As a member of the androgen class, the medication carries serious warnings regarding systemic risks. These include the potential for stimulating the growth of pre-existing prostate cancer and worsening the symptoms of Benign Prostatic Hypertrophy (BPH). Furthermore, use is associated with the risk of Major Adverse Cardiovascular Events (MACE), such as non-fatal myocardial infarction and stroke, and the risk of Venous Thromboembolism (VTE) (DVT/PE).

Population-Specific Safety Constraints

Use is contraindicated in men with known or suspected prostate cancer or carcinoma of the breast. Safety information highlights specific considerations for certain groups: in older adults, careful monitoring of PSA is necessary, and use in pediatric patients is not indicated due to the risk of accelerating bone maturation and premature epiphyseal closure. Additionally, the label notes that the use of androgens may exacerbate edema in patients with severe cardiac, renal, or hepatic disease.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory information for Natesto overdose is primarily based on mandated management actions for over-exposure to testosterone and reported risks associated with the drug class. No cases of overdose with Natesto were reported during the medication’s clinical trials.

Property Official Regulatory Statement
Documented Manifestations No cases of overdose were reported in Natesto clinical trials. Over-exposure may result in testosterone levels substantially exceeding the normal range.
Immediate Action Required The medication must be discontinued immediately upon suspicion of overdosage.
Emergency Management Appropriate symptomatic and supportive care must be provided. Seek medical attention promptly for this care.
Antidote No specific antidote is described or prescribed in the official labeling.
Serious Outcomes Abuse and misuse of anabolic androgenic steroids are associated with potential serious adverse reactions, including adverse cardiovascular and psychiatric events.

In the event of suspected overdosage, urgent medical help must be sought for the administration of symptomatic and supportive care, as this is the standard management procedure directed by regulatory authorities. The profile highlights that the potential for severe outcomes, including those affecting the cardiovascular system, is noted within the context of abuse and misuse of androgens, which results in chronic, excessive exposure.

Therapeutic Uses of Natesto

The intranasal testosterone gel is commonly used exclusively for Testosterone Replacement Therapy (TRT) in adult males diagnosed with hypogonadism—a documented deficiency or absence of endogenous testosterone production. The primary purpose of this androgen replacement therapy is to help manage hormone levels and may provide symptomatic relief across the three main domains where low testosterone can cause disruption, including Primary Hypogonadism and Hypogonadotropic Hypogonadism.


This therapy supports the long-term management of systemic symptoms related to androgen deficiency. It is applied in addressing symptom clusters that create noticeable physiological strain, such as decreased libido and compromised erectile function, alongside persistent fatigue and adverse changes in mood and body composition. The symptomatic relief provided is considered relevant because:

“The primary goal of this therapy is to help ease the overall symptom burden caused by hormonal deficiency, supporting functional stability.”

By correcting the underlying deficiency, the treatment may assist with managing energy levels, improve focus, and contributes to supporting emotional stability for daily functioning. It supports the long-term maintenance of bone mineral density and is used for managing or supporting lean muscle mass.

Quick Fact: Relief for Fatigue Treatment helps manage symptoms related to fatigue and symptoms of diminished sense of vitality often experienced by men with documented testosterone deficiency.

Eligibility and Restrictions for Use

Natesto (testosterone intranasal gel) is strictly approved for use only in adult males (age 18 and older) who have a documented deficiency of endogenous testosterone (hypogonadism), as defined by regulatory authorities.


Populations That Must Not Use Natesto (Contraindications)

Official labeling defines several absolute contraindications, meaning the medicine must not be used in these populations:

  • Males with known or suspected carcinoma of the breast or prostate.
  • All females, including those who are pregnant or may become pregnant.
  • Patients with a history of hypersensitivity or allergic reaction to any component of the product.

Age and Condition Restrictions

  • Pediatric Use: Safety and efficacy are not established for those under 18 years of age. Use is generally prohibited due to the risk of accelerating bone maturation.
  • Specific Conditions: Use is not recommended in men with uncontrolled hypertension or certain nasal conditions (e.g., recent nasal surgery, deviated septum). Additionally, the safety and efficacy are not established for men with age-related hypogonadism or a BMI greater than 35 kg/m^2.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation details specific interaction patterns for testosterone nasal gel (Natesto) with certain classes of medicinal products.

Pharmacodynamic and Metabolic Interactions

Co-administration with oral anticoagulants, such as warfarin, may potentiate their effects. This pharmacodynamic alteration necessitates mandatory, frequent monitoring of the patient's International Normalized Ratio (INR) and prothrombin time when testosterone therapy is initiated or discontinued.

Similarly, co-use with insulin or other antidiabetic agents may result in a decrease in blood glucose levels. This potential additive effect on glucose metabolism may require a re-evaluation of the antidiabetic agent's dosage.

Combining the product with corticosteroids or ACTH introduces a risk of increased fluid retention (edema). This specific interaction requires careful monitoring, particularly in populations with pre-existing cardiac, renal, or hepatic disease.

Administration and Timing Restrictions

The intranasal route of administration imposes constraints on co-use with other products delivered via the same route. The product is not recommended for co-administration with other nasally administered drugs, excluding sympathomimetic decongestants, due to the potential for unknown interactions and the risk of reduced systemic absorption.

Mechanism of Action

Genomic Regulation and Androgen Receptor (AR) Agonism

The primary mechanism involves the active ingredient, testosterone, binding to and activating the intracellular Androgen Receptor (AR), a nuclear receptor found in the cytoplasm of target cells. The activated complex translocates to the cell nucleus, where it modulates gene transcription by attaching to specific DNA elements. This genomic action promotes protein synthesis and positive nitrogen balance, which are the biological processes linked to protein anabolism and nitrogen retention.

Dual Receptor Signaling via Hormonal Conversion

Testosterone functions as a pro-hormone, serving as a substrate for two key enzymes: 5alpha-reductase (which creates the highly potent androgen, DHT) and aromatase (which creates the potent estrogen, estradiol). This conversion results in metabolites that interact with two distinct receptor systems (AR and Estrogen Receptors [ERs]), linking the mechanism to signaling pathways that govern skeletal homeostasis and certain central nervous system (CNS) functions.

HPG Axis Feedback and Systemic Balance

The presence of exogenous testosterone triggers a negative feedback loop on the Hypothalamic-Pituitary-Gonadal (HPG) axis, resulting in the suppression of the body's natural output of stimulating hormones (LH and FSH). This suppression is a direct physiological consequence of the mechanism and reflects the engagement of the body's endocrine negative feedback system.

Dosage and Administration Information

How Natesto is Used

Natesto is a prescription medicine delivered as a nasal gel through a metered-dose pump, and its use is strictly guided by instructions established for Testosterone Replacement Therapy (TRT).


Administration and Dosing Schedule

The approved method of administration is intranasal, and the medicine is never to be applied to other parts of the body. The standard regimen for adults involves a total daily dose of 33 mg of testosterone, administered as 11 mg per dose (two pump actuations) applied to the lateral wall of the nostril. This total dose is divided into three separate administrations, taken three times daily (TID), with doses ideally spaced six to eight hours apart.

Category Official Use Principle
Route of Administration Intranasal Gel (via pump actuation)
Standard Dosing 11 mg per dose (2 actuations)
Frequency Pattern Three times daily (TID)
Total Daily Dose 33 mg

Procedural Requirements and Monitoring

For the first use of a new dispenser, the pump must be primed by depressing it 10 times to ensure proper dose delivery. A key procedural instruction is to refrain from sniffing or blowing the nose for one hour after each administration to allow for adequate absorption. The therapy requires periodic monitoring of serum total testosterone levels, which typically begins as early as one month after treatment initiation. The official usage protocol specifies that the medicine should be discontinued if the total testosterone concentration consistently exceeds 1050 ng/dL.

Recent Clinical Evidence

Research evidence / Overview of studies for Natesto

Research conducted for Natesto involved multicenter, short-term clinical trials that explored its use as a testosterone replacement therapy (TRT). These studies focused on measuring the hormonal response observed with the intranasal gel delivery and assessing outcomes related to systemic or functional imbalance reported by participants with diagnosed hypogonadism. Studies help show what has been observed so far.


Evidence for Use in Confirmed Primary and Secondary Hypogonadism

Research conducted for Natesto involved adult men with confirmed low testosterone concentrations (hypogonadism). These trials were primarily open-label (non-blinded), meaning the researchers were aware of the treatment received. The research was designed to examine whether average total serum testosterone concentrations could be achieved and maintained within the normal adult male range (300 to 1050 ng/dL) over a defined time interval of about 90 days.

Studies monitor changes measured during the study period using standardized instruments. This included assessments of outcomes related to systemic or functional imbalance and psychological measures, such as mood and affect.

Studies on Symptom Assessments and Functional Outcomes

Research examined how symptoms were measured in relation to treatment by using validated questionnaires, such as the International Index of Erectile Function (IIEF). This was used in trials assessing short-term or episodic symptom patterns related to sexual function and libido. Additionally, specific questionnaires were applied in studies examining patient-reported experiences related to mood and well-being.


Long-Term Follow-up and Extended Duration Data

The core effectiveness studies observed participants over a short-term period, usually 90 days. However, some participants continued in open-label safety extension studies, where they were monitored for longer periods, typically up to six months or one year. These extended studies explored the monitoring of outcomes related to systemic or functional imbalance, such as body composition and bone mineral density over time. Findings from these extensions contribute to understanding symptom patterns. However, follow-up durations were limited, meaning long-term effects are not fully established based on the primary research.

What is Still Uncertain about the Evidence Base

A major limitation is the absence of a placebo-controlled arm in the pivotal trial used for regulatory clearance. This means that comparative evidence is lacking for how the observed patterns differ from those seen with an inactive treatment, which represents a research gap. Long-term outcomes related to critical health areas, such as cardiovascular health and prostate changes, are not fully established due to the limited follow-up durations in the primary data set.

Frequently Asked Questions (FAQ)

Common questions about Natesto (FAQ)

Q: How quickly can I expect to see the effects of Natesto?

A: Studies indicate that total testosterone levels are typically maintained within the normal range after about 90 days of treatment. While some patients may notice symptomatic effects earlier, maximum benefit has been observed in clinical trials over several weeks to months. The time it takes to see the effects can vary among individuals.

Q: Will Natesto interact with common blood pressure medications?

A: Official information states that Natesto may increase blood pressure and is not recommended for men with uncontrolled hypertension. Regular monitoring of blood pressure is necessary while using this medicine. Specific drug interactions with every blood pressure medication are not detailed, and regulatory guidance recommends reviewing a full medication list with a healthcare provider.

Q: Should I worry about using Natesto if I take over-the-counter pain relievers?

A: Regulatory information states that patients are advised to always inform their healthcare provider about all medicines and products they are taking. This includes all over-the-counter pain relievers, vitamins, and herbal supplements, to help identify any potential interactions.

Q: Does Natesto have any effect on fertility or sperm count?

A: The use of testosterone replacement therapies like Natesto may suppress the body’s natural production of stimulating hormones. Official warnings indicate that this may lead to adverse effects on semen parameters, including a decrease in sperm count.

Q: Is it possible for Natesto to transfer to a partner or child?

A: Natesto is delivered as an intranasal gel, a method often associated with a lower risk of accidental transfer compared to topical skin gels. However, the product is strictly contraindicated for use in women and children. Adherence to all administration instructions is important to minimize any potential risk of transfer.

Q: Can women accidentally absorb Natesto and experience side effects?

A: Natesto is strictly contraindicated for use in all females. Androgens like testosterone can cause virilizing effects (the development of male characteristics). Accidental absorption by women should be avoided.

Q: Does Natesto cause weight gain or fluid retention?

A: Official warnings note that Natesto can cause fluid retention (edema). This fluid retention may lead to complications for individuals with pre-existing heart, kidney, or liver disease. If unexpected swelling occurs, official guidance suggests reporting this promptly to a healthcare provider.

Q: If I miss a dose of Natesto, what should I do?

A: If a dose is missed, regulatory information advises using it as soon as it is remembered. However, official instructions specify that if it is almost time for the next scheduled dose, the missed dose should be skipped. Do not use two doses at once to make up for a missed dose.

Q: How does Natesto interact with alcohol consumption?

A: The official product information notes a potential interaction with alcohol and food. Given the potential for interaction, consultation with a healthcare provider regarding alcohol consumption is advised.

Q: What are the signs that Natesto is working effectively?

A: Effectiveness is monitored through blood tests to confirm if total testosterone levels are maintained within the target therapeutic range. Clinical trials also observed changes in patient-reported measures of sexual function and overall mood and well-being.

Q: Is there a generic version of Natesto available?

A: Natesto is a brand-name prescription drug. According to current official drug listings, there is no generic version of the testosterone nasal gel available at this time.

Q: Can I use decongestant nasal sprays while I'm on Natesto?

A: Official information generally advises against using Natesto with other nasally administered drugs. However, this restriction specifically excludes sympathomimetic decongestants, which are noted as an exception to the general restriction against concurrent nasal drug use. The safety of using it with other nasal sprays has not been established.

Q: What happens if I accidentally inhale some of the Natesto gel?

A: Patients are instructed not to sniff the nose for one hour after application to ensure proper absorption. While accidental inhalation is not specifically detailed, common adverse reactions related to the site of application include runny nose or discomfort. Any concerning or severe nasal symptoms observed should be brought to the attention of a healthcare provider.

Q: What's the typical duration of Natesto treatment?

A: Natesto is intended for long-term use as part of ongoing testosterone replacement therapy, subject to continuous medical evaluation. The duration of use is determined by a healthcare provider based on monitoring and individual patient need.

Q: Is nasal dryness common when using Natesto?

A: Official safety data lists common adverse reactions related to the site of application. These include nasal discomfort, irritation, and nasal scab, which may be associated with dryness in the nose.

Q: Why is Natesto only applied in the nose?

A: Natesto is formulated as an intranasal gel, and the approved instructions for use specify that the product is only to be administered into the nose. The safety and efficacy of applying this medicine to any other part of the body have not been established.

Q: Can using Natesto improve bone density?

A: Testosterone plays a role in skeletal development. While extended studies have monitored outcomes related to bone, the official product information does not make a specific claim that Natesto improves bone density.

Q: Does Natesto cause hair loss or acne?

A: Official safety data lists acne as a potential side effect of using Natesto. Any occurrence of acne or other skin changes should be discussed with a healthcare professional.

Q: Can Natesto affect my sleep or mood?

A: Clinical studies observed changes in mood, reporting substantial improvements in positive mood and reductions in negative mood. However, the regulatory label also warns that sleep apnea can occur, particularly in men with risk factors, and depression is listed as a serious side effect.

Q: Are there any long-term side effects of using Natesto nasal gel?

A: Official trial data on the nasal safety of Natesto is based on studies up to one year. However, as an androgen, the medication carries systemic risks that require long-term monitoring, including potential effects on the heart, blood cells, and prostate health.

Q: What is the best time of day to apply Natesto?

A: Official product information describes the dosing schedule as three times daily (TID)—once in the morning, afternoon, and evening—with doses ideally spaced six to eight hours apart.

Q: Is Natesto a controlled substance?

A: Yes, Natesto contains testosterone and is legally classified as a Schedule CIII controlled substance under the federal Controlled Substances Act.

Q: Will using Natesto affect my cholesterol levels?

A: Official product information states that Natesto can cause changes in the body's lipid (fat) levels, including cholesterol levels. Official guidance indicates that healthcare providers are advised to monitor lipid concentrations periodically during treatment.

Q: What should I do if I get a bad headache after using Natesto?

A: Headache is listed in official documents as a common adverse reaction. If a severe or concerning headache is experienced, or if it is accompanied by other serious symptoms, seeking prompt medical attention is advised.

Q: Can Natesto affect the results of other lab tests?

A: Yes, the use of Natesto may affect the results of certain lab tests. Your healthcare provider will conduct periodic monitoring of specific blood values, including serum total testosterone, PSA (Prostate-Specific Antigen), hematocrit, and lipid concentrations.

Q: What kind of studies were done on Natesto's effectiveness in older men?

A: According to the official prescribing information, the safety and effectiveness of Natesto have not been established in men with 'age-related hypogonadism' (also sometimes called late-onset hypogonadism) in the trials submitted for regulatory clearance.

Q: Can I go swimming shortly after using Natesto?

A: The primary instruction is to avoid blowing or sniffing the nose for one hour post-application to ensure absorption. Activities that might compromise the absorption of the gel during this hour should be considered with a healthcare professional.

How should Natesto be stored and disposed of?

Storage and Disposal Instructions for Natesto

Natesto (testosterone nasal gel) must be stored at Controlled Room Temperature, officially defined as 20 C to 25 C (68 F to 77 F). The label permits brief temperature excursions between 15 C and 30 C (59 F and 86 F).

Storage Requirements

The medicine must be kept in a closed container at room temperature, protected from freezing, excessive heat, moisture, and direct light. A mandatory safety requirement is to keep Natesto and all medicines out of the reach of children to prevent accidental exposure.

Disposal

Used Natesto dispensers must be discarded in household trash. This disposal must be carried out in a way that prevents the accidental exposure of children or pets. The small amount of gel dispensed during the initial priming of a new pump should be washed away with warm water.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Natesto found in:

A-Z Index: